Drug class
Opioid Analgesics- ER (with all antitussive opiates)
The phrase "Opioid Analgesics- ER (with all antitussive opiates)" is an administrative drug-compendium and clinical decision support grouping rather than a recognized formal therapeutic class defined by the FDA. Read more about Opioid Analgesics- ER (with all antitussive opiates)
161 drugs in this class 82 manufacturers
Drugs in Opioid Analgesics- ER (with all antitussive opiates)
PROMETHAZINE-CODEINE (promethazine HCl/codeine)
TRAMADOL HCL ER (tramadol HCl)
TRAMADOL HCL ER (tramadol HCl)
TREZIX (acetaminophen/caffeine/dihydrocodeine bitartrate)
VIRTUSSIN AC (codeine phosphate/guaifenesin)
CODEINE-GUAIFENESIN (codeine phosphate/guaifenesin)
HYDROCODONE-CHLORPHENIRAMNE ER (hydrocodone polistirex/chlorpheniramine polistirex)
METHADONE HCL
The phrase "Opioid Analgesics- ER (with all antitussive opiates)" is an administrative drug-compendium and clinical decision support grouping rather than a recognized formal therapeutic class defined by the FDA.
Functionally, this category encompasses extended-release opioid agonists, along with opioid-based antitussive agents, which primarily act by binding to central nervous system mu-opioid receptors to inhibit ascending pain pathways and suppress medullary cough centers.
In clinical practice, the extended-release analgesic formulations in this group are indicated for severe chronic pain requiring continuous, round-the-clock opioid therapy when alternative treatments prove inadequate, while the associated antitussive agents are used for the symptomatic suppression of nonproductive cough.
-
fda.gov
The phrase "Opioid Analgesics- ER (with all antitussive opiates)" is an administrative drug-compendium and clinical decision support grouping rather than a recognized formal therapeutic class defined by the FDA
-
ucdenver.edu
The phrase "Opioid Analgesics- ER (with all antitussive opiates)" is an administrative drug-compendium and clinical decision support grouping rather than a recognized formal therapeutic class defined by the FDA
-
connectrx.com
Functionally, this category encompasses extended-release opioid agonists, along with opioid-based antitussive agents, which primarily act by binding to central nervous system mu-opioid receptors to inhibit ascending pain pathways and suppress medullary cough centers
-
fda.gov
Functionally, this category encompasses extended-release opioid agonists, along with opioid-based antitussive agents, which primarily act by binding to central nervous system mu-opioid receptors to inhibit ascending pain pathways and suppress medullary cough centers
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.